Michael R. Dumais - Feb 25, 2022 Form 4 Insider Report for RAYTHEON TECHNOLOGIES CORP (RTX)

Signature
/s/ Dana Ng as Attorney-In-Fact
Stock symbol
RTX
Transactions as of
Feb 25, 2022
Transactions value $
-$1,427,682
Form type
4
Date filed
3/1/2022, 04:10 PM
Previous filing
Feb 8, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RTX Common Stock Options Exercise $1.09M +13K +17.96% $83.58 85.4K Feb 25, 2022 Direct F1
transaction RTX Common Stock Sale -$184K -1.88K -2.21% $97.76 83.5K Feb 25, 2022 Direct
transaction RTX Common Stock Sale -$489K -5K -5.99% $97.73 78.5K Feb 25, 2022 Direct
transaction RTX Common Stock Disposed to Issuer -$1.09M -11.1K -14.16% $97.73 67.4K Feb 25, 2022 Direct
transaction RTX Common Stock Options Exercise $1.15M +13.8K +20.5% $83.58 81.2K Feb 28, 2022 Direct F1
transaction RTX Common Stock Sale -$248K -2.44K -3.01% $101.48 78.8K Feb 28, 2022 Direct
transaction RTX Common Stock Sale -$507K -5K -6.35% $101.43 73.8K Feb 28, 2022 Direct
transaction RTX Common Stock Disposed to Issuer -$1.15M -11.4K -15.42% $101.53 62.4K Feb 28, 2022 Direct
holding RTX Common Stock 1.88K Feb 25, 2022 By Savings Plan Trustee

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RTX Stock Appreciation Right Options Exercise $0 -13K -48.48% $0.00 13.8K Feb 25, 2022 Common Stock 13K $83.58 Direct
transaction RTX Stock Appreciation Right Options Exercise $0 -13.8K -100% $0.00* 0 Feb 28, 2022 Common Stock 13.8K $83.58 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.